StocksMedium•12 November 2026•
1 min read
OS Therapies Receives Tax Refund and FDA Updates on Priority Review Vouchers
Key Facts
1OS Therapies received a tax refund and updates from the FDA regarding priority review voucher programs.
OS Therapies received a tax refund and updates from the FDA regarding priority review voucher programs. Investing.com reported that the company updated shareholders on its liquidity position and the regulatory status of its eligibility for voucher programs concerning its therapeutic developments.
OSTX closed at $0.8722 on November 11, 2026, with a day high of $0.94 and a day low of $0.86. These regulatory and financial developments come as the company manages its liquidity and advances its therapeutic pipeline through US health authority protocols.